We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B Turnover 41.06%
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+4.31%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
+$292M
Cap. Flow
+$65.8M
Cap. Flow %
4.59%
Top 10 Hldgs %
64.89%
Holding
82
New
14
Increased
33
Reduced
12
Closed
20
Avg Time Held Equity + Options
1.2 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
1.3 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.9 years

Top Buys

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$37.3M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$35M
3
AMRN icon
Amarin Corp
AMRN
+$19.9M
4
AMED icon
Amedisys
AMED
+$19.4M
5
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$14.7M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$77.7M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$27.1M
3
NVST icon
Envista
NVST
+$21.6M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$17.9M
5
HLN icon
Haleon
HLN
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 76.06%
2 Miscellaneous 22.43%
3 Financials 0.95%
4 Communication Services 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
GH icon
26
Guardant Health
GH
$21.3B
$11.3M 0.79%
483,098
+336,969
+231% +$9.62M
2021 Q1
8 quarters
PCVX icon
27
Vaxcyte
PCVX
$10B
$11.2M 0.78%
299,050
+120,597
+68% +$5.12M
2022 Q4
1 quarter
HUM icon
28
Humana
HUM
$49.6B
$11.1M 0.77%
22,762
+1,851
+9% +$915K
2022 Q2
3 quarters
IONS icon
29
Ionis Pharmaceuticals
IONS
$7.14B
$10.8M 0.76%
303,369
+62,394
+26% +$2.34M
2021 Q2
7 quarters
SWAV icon
30
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.3M 0.72%
+47,577
New +$9.27M
2023 Q1
0 quarters
ELV icon
31
Elevance Health
ELV
$92.9B
$9.48M 0.66%
20,615
-7,427
-26% -$3.53M
2020 Q4
9 quarters
THC icon
32
Tenet Healthcare
THC
$21.5B
$8.43M 0.59%
141,892
-112,694
-44% -$6.26M
2022 Q4
1 quarter
MODN icon
33
DELISTED
MODEL N, INC.
MODN
$8.1M 0.56%
241,870
+23,990
+11% +$875K
2022 Q4
1 quarter
HCA icon
34
HCA Healthcare
HCA
$99.3B
$7.36M 0.51%
+27,909
New +$7.09M
2023 Q1
0 quarters
XENE icon
35
Xenon Pharmaceuticals
XENE
$3.24B
$7.28M 0.51%
203,272
-72,432
-26% -$2.68M
2021 Q4
5 quarters
AMRX icon
36
Amneal Pharmaceuticals
AMRX
$6.68B
$7.2M 0.5%
5,183,046
+4,352,086
+524% +$8.67M
2020 Q2
11 quarters
XBI icon
37
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.54B
$6.1M 0.43%
+80,000
New +$6.64M
2023 Q1
0 quarters
PNTG icon
38
Pennant Group
PNTG
$1.46B
$6.03M 0.42%
+421,974
New +$5.29M
2023 Q1
0 quarters
PBYI icon
39
Puma Biotechnology
PBYI
$507M
$5.99M 0.42%
1,938,088
+430,425
+29% +$1.62M
2021 Q3
6 quarters
TARO icon
40
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$5.96M 0.42%
245,267
+19,805
+9% +$578K
2019 Q4
13 quarters
ZLAB icon
41
Zai Lab
ZLAB
$2.6B
$5.72M 0.4%
+171,999
New +$6.6M
2023 Q1
0 quarters
LQDA icon
42
Liquidia Corp
LQDA
$3.07B
$5.01M 0.35%
724,406
-566,507
-44% -$3.87M
2021 Q1
8 quarters
AMN icon
43
PUT
AMN Healthcare
AMN
$1.57B
$3.32M 0.23%
+40,000
New +$3.77M
2023 Q1
0 quarters
IQV icon
44
IQVIA
IQV
$43.9B
$2.87M 0.2%
14,416
+3,527
+32% +$754K
2020 Q4
9 quarters
HSKA
45
DELISTED
Heska Corp
HSKA
$2.58M 0.18%
26,409
+6,934
+36% +$581K
2019 Q1
16 quarters
BHVN icon
46
Biohaven
BHVN
$1.63B
$2.54M 0.18%
185,595
– –
2022 Q4
1 quarter
MRUS icon
47
DELISTED
Merus
MRUS
$2.37M 0.17%
129,056
-55,500
-30% -$967K
2021 Q4
5 quarters
MEDP icon
48
Medpace
MEDP
$17.3B
$2.19M 0.15%
+11,668
New +$2.41M
2023 Q1
0 quarters
GOCO icon
49
DELISTED
GoHealth
GOCO
$2.04M 0.14%
125,053
+74,531
+148% +$1.15M
2022 Q4
1 quarter
XOMA icon
50
DELISTED
Xoma
XOMA
$1.9M 0.13%
89,950
+3,077
+4% +$64.7K
2022 Q3
2 quarters
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

Eversept Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Eversept Partners held 82 positions worth $1.43B, up 26% from $1.14B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eversept Partners deployed $65.8M of net new capital in Q1 2023, opening 14 new positions and adding to 33 existing holdings. Its largest new stake was Amedisys: 224,263 shares worth $16.5M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 90% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $27.1M trimmed.

  • Eversept Partners's largest Q1 2023 buy was Amedisys: 224,263 shares worth $16.5M.
  • Eversept Partners added most to Community Health Systems in Q1 2023, an estimated $37.3M increase.
  • Eversept Partners's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $27.1M.
  • Eversept Partners fully exited Sanofi in Q1 2023, selling an estimated $77.7M.
  • Eversept Partners's ten largest holdings make up 65% of its $1.43B portfolio in Q1 2023.
  • Eversept Partners opened 14 new positions and closed 20 in Q1 2023.
  • Eversept Partners's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.